ABL Home - ABL, Inc.
ABL Inc. ABL conquers today’s most challenging diseases through developing our clients novel gene therapies, vaccines, oncolytics and...
Read Ablinc.com news digest here: view the latest ABL Inc articles and content updates right away or get to their most visited pages. Ablinc.com is not yet rated by Alexa and its traffic estimate is unavailable. It seems that ABL Inc content is notably popular in USA. We haven’t detected security issues or inappropriate content on Ablinc.com and thus you can safely use it. Ablinc.com is hosted with DigitalOcean, LLC (Canada) and its basic language is English.
Content verdict: Safe
Website availability: Live
Language: English
Last check:
-
N/A
Visitors daily -
N/A
Pageviews daily -
4
Google PR -
N/A
Alexa rank
Best pages on Ablinc.com
-
ABL conquers today’s most challenging diseases through developing our clients novel gene therapies, vaccines, oncolytics and immunotherapies.
-
ABL values our customers. We'd love to hear from you. Please submit any inquiries, feedback and support and an ABL representative will contact you shortly.
-
Privacy Policy Privacy Policy Statement Advanced BioScience Laboratories, Inc. (“ABL”) and its affiliates (“We”, “Us” or “Our”) are committed to protecting the privacy and personal data of Users of th...
Ablinc.com news digest
-
5 years
NFL Testing Using Ultrasensitive Immunoassay
Testing Neurofilament Light (NF-L) chain in blood samples to monitor neurodegenerative diseases and support clinical drug development: qualification of an ultrasensitive immuno-assay using clinical serum and plasma samples.u00a0
Download Now
The post NFL Testing Using Ultrasensitive Immunoassay appeared first on ABL, Inc..... -
5 years
ABL will be attending the AAPS PharmSci 360 Annual Meeting from November 4-7 in Washington, D.C.
Meet us at booth 719.
The post AAPS PharmSci 360 appeared first on ABL, Inc.. -
5 years
Accelerating Vaccine Production
At the recent World Vaccine Conference, Victor Ayala, PhD, an early stage investigator with Advanced BioScience Laboratories, Inc. (ABL), discussed how to accelerate vaccine production using a nonviral enabling technology for cell engineering. The above...
-
5 years
ABL Europe Facility – Strasbourg, France
Check out the video of our dedicated viral vector cGMP licensed facility in Strasbourg, France. GMP services for your oncolytic, vaccine and gene therapy projects in all phases of clinical development & upon product approval.
The post ABL Europe Facility – Strasbourg, France appeared first on ABL, Inc.....
Domain history
| Web host: | DigitalOcean, LLC |
| Registrar: | Network Solutions, LLC |
| Registrant: | PERFECT PRIVACY, LLC |
| Updated: | December 14, 2022 |
| Expires: | January 25, 2028 |
| Created: | January 26, 1998 |
Whois record
Safety scores
Trustworthiness
N/AChild safety
N/A
